SCHEMBL170662

SCHEMBL170662

O=C(CO)NNO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7108066 0.85 OR51E2 (0.33)
SCHEMBL8638776 0.76 LDHA (0.35)
SCHEMBL195623 0.74
SCHEMBL6773592 0.73
SCHEMBL9912442 0.73
SCHEMBL7396316 0.72 ECE1 (0.41)
SCHEMBL2113139 0.71
SCHEMBL29039515 0.71 ALDH1A1 (0.43)
SCHEMBL2373214 0.69
SCHEMBL31107449 0.69

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108530637-B Preparation method of single-functionalized branched polyethylene glycol 厦门赛诺邦格生物科技股份有限公司 2021-03-30 CN claimed
CN-112023122-A In-situ injection jelly as well as preparation method and application thereof 北京爱特康医疗科技有限公司 2020-12-04 CN claimed
US-20070135349-A1 Method for increasing the serum half-life of a biologically active molecule DRUMMOND ROBERT J 2007-06-14 US claimed
US-20070060513-A9 Method for increasing the serum half-life of a biologically active molecule DRUMMOND ROBERT J 2007-03-15 US claimed
US-20050197297-A1 Method for increasing the serum half-life of a biologically active molecule DRUMMOND ROBERT J (US) 2005-09-08 US claimed
EP-1062230-B1 METHOD FOR INCREASING THE SERUM HALF-LIFE OF A BIOLOGICALLY ACTIVE MOLECULE CHIRON CORP (US) 2004-10-13 EP claimed
US-20020182705-A1 Method for increasing the serum half-life of a biologically active molecule CHIRON CORPORATION 2002-12-05 US claimed
US-6423685-B1 CONJUGATING POLYMER (POLYETHYLENE GLYCOL) TO BIOLOGICALLY ACTIVE MOLECULE (POLYPEPTIDE); HUMAN UROKINASE PLASMINOGEN ACTIVATOR CHIRON CORPORATION 2002-07-23 US claimed
US-20020086819-A1 METHOD FOR INCREASING THE SERUM HALF-LIFE OF A BIOLOGICALLY ACTIVE MOLECULE CHIRON CORPORATION 2002-07-04 US claimed
EP-1062230-A1 METHOD FOR INCREASING THE SERUM HALF-LIFE OF A BIOLOGICALLY ACTIVE MOLECULE Chiron Corporation (US) 2000-12-27 EP claimed
WO-1999045026-A1 METHOD FOR INCREASING THE SERUM HALF-LIFE OF A BIOLOGICALLY ACTIVE MOLECULE CHIRON CORPORATION (US) 1999-09-10 WO claimed
US-5547981-A Taxol-7-carbazates ENZON, INC. (US) 1996-08-20 US claimed
CN-117487043-A Aldehyde hyaluronic acid derivative and preparation method thereof 中国科学院长春应用化学研究所 2024-02-02 CN disclosed
WO-2023114418-A1 IMPLANTABLE SCAFFOLDS FOR IMMUNOTHERAPEUTIC AND OTHER USES THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2023-06-22 WO disclosed
CN-108530636-B Single functionalized branched polyethylene glycol 厦门赛诺邦格生物科技股份有限公司 2021-05-28 CN disclosed
CN-108530637-B Preparation method of single-functionalized branched polyethylene glycol 厦门赛诺邦格生物科技股份有限公司 2021-03-30 CN disclosed
WO-2001043774-A1 METHODS OF TREATING CENTRAL NERVOUS SYSTEM ISCHEMIC OR HEMORRHAGIC INJURY USING ANTI ALPHA4 INTEGRIN ANTAGONISTS BIOGEN, INC. (US) 2001-06-21 WO disclosed
WO-2000064474-A1 METHOD FOR THE TREATMENT OF FIBROSIS USING AN ANTAGONIST OF THE INTEGRIN ALPHA-4 SUBUNIT BIOGEN, INC. (US) 2000-11-02 WO disclosed
WO-2000023114-A2 POLYMER CONJUGATES OF INTERFERON BETA- 1A AND THEIR USES BIOGEN, INC. (US) 2000-04-27 WO disclosed
US-5547981-A Taxol-7-carbazates ENZON, INC. (US) 1996-08-20 US disclosed